QuidelOrtho's (QDEL) reported weakness is concentrated in post-COVID Point of Care and the deliberate US donor-screening exit ...

The findings of this study suggest that a community-based point-of-care hepatitis C virus (HCV) RNA testing program was feasible and was associated with a high percentage of same-day treatment for ...

A clinician-led approach boosts genetic testing among relatives of people with newly detected pathogenic variants — and could help close a gap in hereditary cancer prevention.

QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, announced today it has completed the acquisition of LEX Diagnostics ("LEX") ...

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has secured a significant expansion of the US commercial rollout for its ...

South Korean researchers have developed a method to bypass a fundamental limitation in biosensors, a step that could ...

The first time Dr. Anita Chopra had a long COVID patient, she cried. It was two years after the pandemic, she said, when the once-healthy patient described symptoms of weakness, chronic fatigue and ...

Phoebe Tesoriere, 23, of Cardiff, Wales, said she had balance problems as a child and was tested for a condition called ...

A new study found people who drink fluoridated water long-term are just as smart as those who don't, contrary to RFK Jr.'s ...

Advocates press Albany to ban toxic beauty chemicals after new tests found concerning ingredients in products sold to ...

The federal government summoned financial leaders to an emergency meeting over Claude Mythos last week.

It’s “a move away from a one-size-fits-all framework for Alzheimer’s disease.” ...